Legal provisions of COM(2018)31 - EU position in the sixty-first session of the Commission on Narcotic Drugs on the scheduling of substances

Please note

This page contains a limited version of this dossier in the EU Monitor.

dossier COM(2018)31 - EU position in the sixty-first session of the Commission on Narcotic Drugs on the scheduling of substances.
document COM(2018)31 EN
date January 12, 2018


Article 1

The position to be adopted on the Union's behalf in the sixty-first session of the Commission on Narcotic Drugs from 12 to 16 March 2018, when that body is called upon to adopt decisions on the addition of substances to the Schedules of the United Nations Single Convention on Narcotic Drugs of 1961 as amended by the 1972 Protocol and the United Nations Convention on Psychotropic Substances of 1971, is set out in the Annex.

Proposal for a Council Implementing Decision on subjecting the new psychoactive substance methyl 2-{[1-(5-fluoropentyl)-1H-indazole-3-carbonyl]amino}-3,3-dimethylbutanoate (5F-MDMB-PINACA) to

26

Article 2

The position referred to in Article 1 shall be expressed by the Member States that are members of the Commission of Narcotic Drugs, acting jointly.

Article 3 This Decision is addressed to the Member States in accordance with the Treaties.